CRSP stock news
This page provides real-time market news, earnings updates, and company announcements related to CRISPR Therapeutics AG (CRSP).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-10 02:51 EST
Is Now a Good Time to Invest in CRISPR Therapeutics Stock?
101 finance2026-03-20 12:30:13
Is Now a Good Time to Invest in CRISPR Therapeutics Stock?
101 finance2026-03-20 12:36:47
Vertex Shares Drop 4.8% Over the Past Month: Is This a Chance to Buy or a Warning Sign?
101 finance2026-03-20 13:03:54
Aera Therapeutics: A Bold Platform Gamble Dependent on 2026 Clinical Milestone for AERA-109
101 finance2026-03-22 00:21:56
Cathie Wood’s CRISPR Investment: Seizing the Downturn During Biotech Volatility and Positioning for a Speculation-Fueled Comeback
101 finance2026-03-22 00:39:40
CRISPR's $2.56B Cash Reserve Masks a High-Potential Pipeline Opportunity During Market Fluctuations and Strong Institutional Confidence
101 finance2026-03-22 00:39:42
2022 IRS Refunds Still Available: How to Get Your Unclaimed Money
101 finance2026-03-22 04:06:41
CRISPR holds a $2 billion cash reserve, while a $270 million sales trigger emerges: Will Casgevy provide the necessary margin of safety?
101 finance2026-03-22 06:33:55
The rapid market launch of CRISPR's Casgevy may be the key factor behind its potential to surge over 75%.
101 finance2026-03-22 07:15:45
CRISPR’s Robust Development Process and Solid Financial Position Present Undervalued Growth Potential as Regulatory Events Unfold
101 finance2026-03-22 07:33:47
ARKK’s Subdued Week: Three Purchases, $15 Billion in Flows, and Market Price Effects
101 finance2026-03-23 17:15:55
CRISPR Therapeutics Stock: Should You Consider Buying It at This Price?
101 finance2026-03-23 18:03:51
Tempest Therapeutics (TPST) Plummets 24% Intraday: What Sent a Biotech Stock Into Freefall?
101 finance2026-03-23 18:04:22
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Finviz2026-03-25 12:03:58
Why CRISPR Therapeutics AG (CRSP) Performed Better Than the Market Today
101 finance2026-03-25 22:58:06
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
Finviz2026-03-27 11:03:57
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Finviz2026-03-31 12:06:47
Synthego's Supreme Court Win Clears Patent Overhang—CRISPR Pure-Play Setup Gains Traction
101 finance2026-04-01 20:30:38
CRISPR Therapeutics AG (CRSP) Outperforms the Market: Key Points to Note
101 finance2026-04-01 23:03:56
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 20:06:43
Replimune’s Bullish Tech Signal vs. Uncertain Biotech Landscape
101 finance2026-04-04 00:09:42
CRSP Sickle Cell Disease - The Saudis were talking about it Yest
TradingView2026-04-06 03:06:22
Intellia's FDA Approval Opens Strategic Opportunity for Revaluation Despite Pipeline Delays and Safety Concerns
101 finance2026-04-08 09:57:42
Vertex’s CASGEVY Set to Broaden Reach as Gene Editing Approach Advances in Pediatric Studies
101 finance2026-04-08 11:15:47
Cathie Wood’s CRISPR Investment: Seizing the Downturn During Biotech Volatility and Positioning for a Speculation-Fueled Comeback
101 finance2026-03-22 00:39:40
CRISPR's $2.56B Cash Reserve Masks a High-Potential Pipeline Opportunity During Market Fluctuations and Strong Institutional Confidence
101 finance2026-03-22 00:39:42
2022 IRS Refunds Still Available: How to Get Your Unclaimed Money
101 finance2026-03-22 04:06:41
CRISPR holds a $2 billion cash reserve, while a $270 million sales trigger emerges: Will Casgevy provide the necessary margin of safety?
101 finance2026-03-22 06:33:55
The rapid market launch of CRISPR's Casgevy may be the key factor behind its potential to surge over 75%.
101 finance2026-03-22 07:15:45
CRISPR’s Robust Development Process and Solid Financial Position Present Undervalued Growth Potential as Regulatory Events Unfold
101 finance2026-03-22 07:33:47
ARKK’s Subdued Week: Three Purchases, $15 Billion in Flows, and Market Price Effects
101 finance2026-03-23 17:15:55
CRISPR Therapeutics Stock: Should You Consider Buying It at This Price?
101 finance2026-03-23 18:03:51
Tempest Therapeutics (TPST) Plummets 24% Intraday: What Sent a Biotech Stock Into Freefall?
101 finance2026-03-23 18:04:22
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Finviz2026-03-25 12:03:58
Why CRISPR Therapeutics AG (CRSP) Performed Better Than the Market Today
101 finance2026-03-25 22:58:06
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
Finviz2026-03-27 11:03:57
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Finviz2026-03-31 12:06:47
Synthego's Supreme Court Win Clears Patent Overhang—CRISPR Pure-Play Setup Gains Traction
101 finance2026-04-01 20:30:38
CRISPR Therapeutics AG (CRSP) Outperforms the Market: Key Points to Note
101 finance2026-04-01 23:03:56
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 20:06:43
Replimune’s Bullish Tech Signal vs. Uncertain Biotech Landscape
101 finance2026-04-04 00:09:42
CRSP Sickle Cell Disease - The Saudis were talking about it Yest
TradingView2026-04-06 03:06:22
Intellia's FDA Approval Opens Strategic Opportunity for Revaluation Despite Pipeline Delays and Safety Concerns
101 finance2026-04-08 09:57:42
Vertex’s CASGEVY Set to Broaden Reach as Gene Editing Approach Advances in Pediatric Studies
101 finance2026-04-08 11:15:47
CRSP stock chart
CRSP stock detailsCRSP stock price change
On the last trading day, CRSP stock closed at 51.76 USD, with a price change of 4.14% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more